跳至主要内容
临床试验/TCTR20220627002
TCTR20220627002Unknown4 期

The efficacy and safety of monopolar radiofrequency for treatment of moderate-to-severe recalcitrant acne

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand0 个研究点目标入组 15 人开始时间: 2022年6月27日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Aged from 18 years or older
  • 2. Were diagnosed with moderate to severe recalcitrant acne by dermatologist
  • 3. The patient who were not responded by standard treatment, for example, topical treatments and oral antibiotics at least 3 month and have to hold any treatment for 1 month

排除标准

  • 1. Patients who are pregnant, lactating, and postpartum within 1 year
  • 2. Patients who taking oral isotretinoin within 1 year
  • 3. Patients with other skin disease, or having infection at the area of face
  • 4. Immunocompromised patients
  • 5. Patients with hypertrophic scar or keloid
  • 6. Patients with history of Cushing syndrome or Ehlers-Danlos syndromd
  • 7.Patients with cancers or skin cancers
  • 8.Patients with mental disorders
  • 9.Patiens with chemical peels within 1 month
  • 10. patient with herpes simplex infection

研究者

发起方
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

相似试验